| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Marta Fumagalli | Q57632102 |
| Claudia Verderio | Q42887667 | ||
| P2093 | author name string | Pierre Gressens | |
| Marta Lombardi | |||
| P2860 | cites work | Aldose reductase inhibitors attenuate β-amyloid-induced TNF-α production in microlgia via ROS-PKC-mediated NF-κB and MAPK pathways. | Q50939879 |
| Systemic inflammation disrupts the developmental program of white matter. | Q50998316 | ||
| The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling. | Q51320013 | ||
| Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. | Q51748258 | ||
| miR-124 Contributes to the functional maturity of microglia. | Q52151941 | ||
| Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway. | Q52308742 | ||
| 2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs. | Q52372355 | ||
| Metabolic Modulation in Macrophage Effector Function. | Q52665600 | ||
| Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. | Q54108748 | ||
| General nature of the STAT3-activated anti-inflammatory response. | Q54570920 | ||
| Macrophage-Derived Extracellular Succinate Licenses Neural Stem Cells to Suppress Chronic Neuroinflammation. | Q54960194 | ||
| NGF steers microglia toward a neuroprotective phenotype. | Q55250655 | ||
| Mesenchymal Stem Cells Shape Microglia Effector Functions Through the Release of CX3CL1 | Q57658201 | ||
| Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells | Q61479730 | ||
| Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells | Q82371560 | ||
| Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury | Q82452721 | ||
| A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation | Q84117546 | ||
| The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ | Q84589575 | ||
| miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia | Q84831515 | ||
| The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity | Q88644741 | ||
| Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol | Q24336876 | ||
| HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1 | Q24339505 | ||
| Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators | Q24557011 | ||
| MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases | Q26744819 | ||
| Sirtuin functions and modulation: from chemistry to the clinic | Q26745884 | ||
| Involvement of microRNA in microglia-mediated immune response | Q26851399 | ||
| AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function | Q26865723 | ||
| MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS | Q27025394 | ||
| The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes | Q27303048 | ||
| Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. | Q27317371 | ||
| Alternative activation of macrophages | Q27860939 | ||
| PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease | Q28069549 | ||
| Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response | Q28083164 | ||
| All in the family: aldose reductase and closely related aldo-keto reductases | Q28257368 | ||
| Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner | Q28267444 | ||
| Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study | Q28273200 | ||
| Brain inflammation and adult neurogenesis: the dual role of microglia | Q28288892 | ||
| Identification of a unique TGF-β-dependent molecular and functional signature in microglia | Q28303557 | ||
| A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases | Q28382891 | ||
| Early mitochondrial dysfunction in long-lived Mclk1+/- mice | Q28585518 | ||
| Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha | Q28589867 | ||
| p38α mitogen-activated protein kinase depletion and repression of signal transduction to translation machinery by miR-124 and -128 in neurons | Q28710107 | ||
| Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 | Q28975612 | ||
| Synaptic pruning by microglia is necessary for normal brain development | Q29615591 | ||
| Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
| MicroRNA control in the immune system: basic principles | Q29618112 | ||
| Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages | Q29620142 | ||
| A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
| Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke | Q30422954 | ||
| Differential roles of microglia and monocytes in the inflamed central nervous system | Q30585165 | ||
| Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery | Q30912007 | ||
| Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis | Q33560182 | ||
| Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 | ||
| MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination | Q48196810 | ||
| Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury. | Q48262918 | ||
| PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. | Q48273067 | ||
| Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle. | Q48283206 | ||
| Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways. | Q48284134 | ||
| The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. | Q48319804 | ||
| MiR-124 contributes to M2 polarization of microglia and confers brain inflammatory protection via the C/EBP-α pathway in intracerebral hemorrhage. | Q48381200 | ||
| Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia. | Q48425876 | ||
| MiR-29 family members interact with SPARC to regulate glucose metabolism. | Q49808575 | ||
| Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development. | Q50105551 | ||
| MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1. | Q50198629 | ||
| Dicer Deficiency Differentially Impacts Microglia of the Developing and Adult Brain. | Q50573544 | ||
| Microglial microvesicle secretion and intercellular signaling. | Q38015845 | ||
| Regulation of microglia activation and deactivation by nuclear receptors | Q38044319 | ||
| Commonly used endocrine drugs | Q38173524 | ||
| Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease | Q38203104 | ||
| Grafted bone marrow stromal cells: a contributor to glial repair after spinal cord injury | Q38207902 | ||
| Metabolism of stromal and immune cells in health and disease | Q38227775 | ||
| Are "resting" microglia more "m2"? | Q38283533 | ||
| Hormones and diet, but not body weight, control hypothalamic microglial activity | Q38311585 | ||
| Effect of pioglitazone medication on the incidence of dementia | Q38414756 | ||
| The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E. | Q38442115 | ||
| Pathological differences between white and grey matter multiple sclerosis lesions | Q38551949 | ||
| TREM2 in Neurodegenerative Diseases | Q38646212 | ||
| Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: Critical role of PPAR-γ signaling pathway | Q38652797 | ||
| Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells | Q38726999 | ||
| Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype. | Q38752410 | ||
| Regulation of Insulin Resistance by Multiple MiRNAs via Targeting the GLUT4 Signalling Pathway | Q38771909 | ||
| MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages | Q38800449 | ||
| KCa 3.1-a microglial target ready for drug repurposing? | Q38819263 | ||
| MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells. | Q38845893 | ||
| Bioactive lipids as new class of microglial modulators: When nutrition meets neuroimunology | Q38890532 | ||
| Overexpression of SIRT1 Induced by Resveratrol and Inhibitor of miR-204 Suppresses Activation and Proliferation of Microglia | Q38905183 | ||
| Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders | Q38924913 | ||
| Aldose Reductase Regulates Microglia/Macrophages Polarization Through the cAMP Response Element-Binding Protein After Spinal Cord Injury in Mice | Q38927552 | ||
| MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies. | Q38928442 | ||
| Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. | Q38988403 | ||
| Microglia in Physiology and Disease. | Q39037459 | ||
| MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. | Q39062871 | ||
| MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway | Q39116117 | ||
| Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases | Q39116758 | ||
| The roles of histamine and its receptor ligands in central nervous system disorders: An update | Q39145707 | ||
| Microglia Function in the Central Nervous System During Health and Neurodegeneration | Q39146780 | ||
| Fingolimod phosphate promotes the neuroprotective effects of microglia | Q39216224 | ||
| Modulators of microglial activation and polarization after intracerebral haemorrhage | Q39317715 | ||
| Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions | Q39412699 | ||
| The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke | Q35880549 | ||
| A Distinct Population of Microglia Supports Adult Neurogenesis in the Subventricular Zone | Q35995933 | ||
| Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease | Q35999547 | ||
| A novel small-molecule agonist of PPAR-γ potentiates an anti-inflammatory M2 glial phenotype | Q36049405 | ||
| Identifying functional microRNAs in macrophages with polarized phenotypes | Q36052406 | ||
| Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. | Q36190713 | ||
| MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative macrophage activation | Q36266476 | ||
| Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). | Q36283527 | ||
| Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI | Q36459432 | ||
| Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders | Q36497184 | ||
| TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques | Q36863174 | ||
| Activated microglia enhance neurogenesis via trypsinogen secretion | Q36884025 | ||
| Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases | Q36918509 | ||
| Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro | Q36959383 | ||
| Role of arginine metabolism in immunity and immunopathology | Q37034571 | ||
| GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. | Q37197952 | ||
| The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. | Q37217396 | ||
| Microglial CX3CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX3CL1 | Q37263310 | ||
| MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines | Q37279851 | ||
| miR-181a Induces Macrophage Polarized to M2 Phenotype and Promotes M2 Macrophage-mediated Tumor Cell Metastasis by Targeting KLF6 and C/EBPα. | Q37325088 | ||
| The microglial sensome revealed by direct RNA sequencing | Q37341692 | ||
| miR-125a-5p regulates differential activation of macrophages and inflammation. | Q37368700 | ||
| miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma | Q37565493 | ||
| The role of sirtuins in the control of metabolic homeostasis | Q37596557 | ||
| M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination | Q37687158 | ||
| Sensing of energy and nutrients by AMP-activated protein kinase. | Q37843126 | ||
| The role of microglia in the healthy brain. | Q37954595 | ||
| Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling | Q39511870 | ||
| Cytoprotective and anti-inflammatory effects of spinasterol via the induction of heme oxygenase-1 in murine hippocampal and microglial cell lines | Q39646341 | ||
| PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways | Q39701130 | ||
| Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization | Q40049777 | ||
| MicroRNA-146a governs fibroblast activation and joint pathology in arthritis. | Q40198192 | ||
| Neuroprotective effect of exogenous microglia in global brain ischemia. | Q40259143 | ||
| Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration | Q40569874 | ||
| Enhanced immunity in slowly aging mutant mice with high mitochondrial oxidative stress | Q40725529 | ||
| Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin | Q41029845 | ||
| 6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ. | Q41091850 | ||
| Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate | Q41166999 | ||
| Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron-Microglia Interactions | Q41449300 | ||
| Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System | Q41595928 | ||
| Integrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infants | Q41620055 | ||
| A G protein-coupled α7 nicotinic receptor regulates signaling and TNF-α release in microglia | Q41627685 | ||
| Histamine regulation of microglia: Gene-environment interaction in the regulation of central nervous system inflammation | Q41635706 | ||
| Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP | Q41693673 | ||
| MicroRNA let-7c regulates macrophage polarization. | Q41855099 | ||
| Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia | Q41887011 | ||
| Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4. | Q42014501 | ||
| Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke | Q42071157 | ||
| Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles. | Q42255726 | ||
| Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways. | Q42709510 | ||
| TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy | Q42736886 | ||
| TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease | Q42777333 | ||
| Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis | Q43247720 | ||
| K+ channels and the microglial respiratory burst | Q43540337 | ||
| Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells | Q43641873 | ||
| Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis | Q44060078 | ||
| Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation | Q44543960 | ||
| Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro | Q44964904 | ||
| Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis | Q45303266 | ||
| Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia | Q45829514 | ||
| Bioenergetic regulation of microglia. | Q46004195 | ||
| Microglia and macrophages in brain homeostasis and disease | Q46461757 | ||
| Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming | Q46468941 | ||
| Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages | Q46485595 | ||
| Identification of a microglia phenotype supportive of remyelination | Q46582759 | ||
| Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn's disease | Q47111006 | ||
| Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations | Q47230692 | ||
| Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept | Q47258976 | ||
| Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway | Q47428394 | ||
| The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases | Q47568641 | ||
| Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease | Q47661204 | ||
| Neural precursor cell-secreted TGF-β2 redirects inflammatory monocyte-derived cells in CNS autoimmunity. | Q47748697 | ||
| Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. | Q47764430 | ||
| MicroRNA Bta-miR-181a regulates the biosynthesis of bovine milk fat by targeting ACSL1. | Q47820627 | ||
| Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX/FPR2 Receptor-Regulated MicroRNAs | Q47847490 | ||
| Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology. | Q47927476 | ||
| Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. | Q48117008 | ||
| Endocannabinoids drive the acquisition of an alternative phenotype in microglia | Q48123098 | ||
| Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling. | Q48181933 | ||
| Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor | Q33671206 | ||
| Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization | Q33675640 | ||
| Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. | Q33727947 | ||
| Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. | Q33770234 | ||
| The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma | Q33779972 | ||
| Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma | Q34000812 | ||
| Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways | Q34035175 | ||
| Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages | Q34071063 | ||
| Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders | Q34126096 | ||
| PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status | Q34203838 | ||
| Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas | Q34212214 | ||
| Peroxisome proliferator-activated receptor gamma and metabolic disease. | Q34275476 | ||
| Succinate: a metabolic signal in inflammation | Q34393631 | ||
| Fasting: molecular mechanisms and clinical applications | Q34398790 | ||
| Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity | Q34536960 | ||
| Localized retinal neuropeptide regulation of macrophage and microglial cell functionality | Q34539859 | ||
| MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. | Q34606028 | ||
| Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia | Q34612008 | ||
| MiR-181a regulates inflammation responses in monocytes and macrophages | Q34629860 | ||
| STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells | Q34641231 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model | Q34746889 | ||
| microRNAs at the synapse | Q35011182 | ||
| Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms | Q35025103 | ||
| Presenilin 2 influences miR146 level and activity in microglia | Q35137238 | ||
| MiR-181a regulates lipid metabolism via IDH1 | Q35148690 | ||
| Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis. | Q35167056 | ||
| Malibatol A regulates microglia M1/M2 polarization in experimental stroke in a PPARγ-dependent manner | Q35229901 | ||
| Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress | Q35231999 | ||
| Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation | Q35242438 | ||
| Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease | Q35470763 | ||
| An updated role of microRNA-124 in central nervous system disorders: a review | Q35626122 | ||
| TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model | Q35771760 | ||
| Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. | Q35856171 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P921 | main subject | encephalitis | Q199615 |
| microglia | Q1622829 | ||
| cellular reprogramming | Q68262545 | ||
| P304 | page(s) | 2531-2549 | |
| P577 | publication date | 2018-09-08 | |
| 2018-12-01 | |||
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | How to reprogram microglia toward beneficial functions | |
| P478 | volume | 66 |
| Q89977775 | Anti-stress, Glial- and Neuro-differentiation Potential of Resveratrol: Characterization by Cellular, Biochemical and Imaging Assays |
| Q97692894 | Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing |
| Q94562610 | Exosomes derived from neural progenitor cells preserve photoreceptors during retinal degeneration by inactivating microglia |
| Q89963836 | Functional and Metabolic Characterization of Microglia Culture in a Defined Medium |
| Q91787847 | Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients |
| Q93192265 | MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia |
| Q92136791 | Microglial activation after ischaemic stroke |
| Q94450925 | Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis |
| Q95265968 | Propofol Attenuates Hypoxia-Induced Inflammation in BV2 Microglia by Inhibiting Oxidative Stress and NF-κB/Hif-1α Signaling |
| Q99724773 | TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions |
Search more.